MetaCap

Prelude Therapeutics Insider Trades

NASDAQ: PRLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.89+0.01 (+0.26%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
4 · $25.00M
Sales
0 · $0
Shares bought / sold
5.63M / 0
Net activity
Net buying $25.0 million

Prelude Therapeutics insider activity

Over the last 12 months, Prelude Therapeutics insiders reported 5 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $25.0 million and sold $0 worth of stock, for net insider buying of $25.0 million. The most recent filing shows RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M. (10% Owner) reporting a transaction in 1,407,000 shares on Apr 27, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PRLD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PRLD insider transactions

Prelude Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Apr 27, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Ownerother1,407,000—Form 4
Apr 21, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & ORBIMED CAPITAL LLC & OrbiMed Genesis GP LLCDirectorBuy1,126,126$5.00MForm 4
Apr 21, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & ORBIMED CAPITAL LLC & OrbiMed Genesis GP LLCDirectorBuy1,689,189$7.50MForm 4
Apr 21, 2026Bonita David PDirectorBuy1,126,126$5.00MForm 4
Apr 21, 2026Bonita David PDirectorBuy1,689,189$7.50MForm 4
Oct 4, 2025Huang JanePresident, CMOTax withholding3,355$4.93KForm 4
Oct 4, 2025Huang JanePresident, CMOOption exercise9,375—Form 4
Jul 4, 2025Huang JanePresident, CMOTax withholding3,355$2.66KForm 4
Jul 4, 2025Huang JanePresident, CMOOption exercise9,375—Form 4
Apr 4, 2025Huang JanePresident, CMOTax withholding3,355$2.26KForm 4
Apr 4, 2025Huang JanePresident, CMOOption exercise9,375—Form 4
Mar 25, 2025Vaddi KrishnaCEOBuy675,000$467.44KForm 4
Mar 25, 2025Combs AndrewChief Chemistry OfficerBuy100,000$69.25KForm 4
Mar 21, 2025Vaddi KrishnaCEOBuy15,000$10.96KForm 4
Mar 20, 2025Vaddi KrishnaCEOBuy5,416$3.95KForm 4
Mar 17, 2025Vaddi KrishnaCEOBuy9,106$6.83KForm 4
Mar 14, 2025Vaddi KrishnaCEOBuy29,999$22.63KForm 4
Mar 13, 2025Vaddi KrishnaCEOBuy50,000$35.82KForm 4
Mar 12, 2025Vaddi KrishnaCEOBuy47,500$33.74KForm 4
Jan 4, 2025Huang JanePresident, CMOTax withholding3,859$5.36KForm 4
Jan 4, 2025Huang JanePresident, CMOOption exercise9,375—Form 4
Dec 31, 2024Vaddi KrishnaCEOBuy5,000$6.04KForm 4
Dec 30, 2024Vaddi KrishnaCEOBuy10,000$12.00KForm 4
Dec 23, 2024Combs AndrewChief Chemistry OfficerBuy60,000$82.00KForm 4
Dec 20, 2024Combs AndrewChief Chemistry OfficerBuy3,075$3.54KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related